BioGenCell is a seed startup based in Israel. 1 investor tracked. Status: zombie.
Based in Israel, BioGenCell is a startup founded in 2013. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
BioGenCell is developing a novel platform for automated manufacturing of personalized cell therapies that induce the regeneration of blood vessels, for the treatment of severe limb-threatening ischemia.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.